Meyka Pro banner
cbdMD, Inc.

cbdMD, Inc. (YCBD) Stock Overview

Explore cbdMD, Inc.’s financial performance, market position, analyst ratings, and future outlook.

YCBDAMEX
HealthcareDrug Manufacturers - Specialty & Generic
$0.56
$0.007(1.28%)
U.S. Market opens in 17h 22m

cbdMD, Inc. (YCBD)

Meyka AI Score

Z

Key Financials

Market Cap5.9M
P/E Ratio-1.40
EPS (TTM)$-0.41
ROE-0.34%
Fundamental Analysis

AI Price Forecasts

1 Month$0.63
3 Months$0.93
1 Year Target$0.00

YCBD Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of cbdMD, Inc. (YCBD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 32.38, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $0.00.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -1.40 and a market capitalization of 5.9M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
1.42%
5-Day Change
-12.85%
1-Month Change
-16.24%
3-Month Change
-28.47%
6-Month Change
-30.45%
Year-to-Date (YTD) Change
-57.19%
1-Year Change
-38.51%
3-Year Change
-94.88%
5-Year Change
-99.94%
All-Time (Max) Change
-99.97%

Contact Information

704 445 3060
2101 Westinghouse Blvd, Charlotte, NC, 28217

Company Facts

420 Employees
IPO DateNov 17, 2017
CountryUS
Actively Trading

Frequently Asked Questions